journal article·2022-02Open access

Red haloBODIPYs as theragnostic agents: The role of the substitution at meso position

Ruth Prieto-Montero, Alejandro Prieto-Castañeda, Alberto Katsumiti, Rebeca Sola-Llano, Antonia R. Agarrabeitia, Miren P. Cajaraville, María J. Ortiz, Virginia Martinez-Martinez

Dyes and Pigments· Volume 198

Abstract

Three different molecular designs based on BODIPY dye have been proposed as photosensitizers (PSs) for photodynamic therapy (PDT) by the inclusion of halogen atoms (Iodine) at 2,6-positions and with extended conjugation at 3, 5-positions and varying the substitution at meso position. The synthesis is described and their main photophysical features including singlet oxygen production and triplet states were characterized by absorption and fluorescence spectroscopy (steady-state and time-correlated) and nanosecond transient absorption spectroscopy. The results were compared with the commercial Chlorin e6. The three new red-halogen-BODIPYs showed a great balance between singlet oxygen generation (ΦΔ≥0.40) and fluorescence (Φfl≥0.22) for potential application on PDT, and particularly in theragnosis. In vitro experiments in HeLa cells were done to study their performance and to elucidate the best potential candidate for PDT.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (78)

Show source-provided references
1. Beyond phototherapy: recent advances in multifunctional fluorescent nanoparticles for light-triggered tumor theranostics10.1002/adfm.201803733 ↗
2. Manipulating charge-transfer states in BODIPYs: a model strategy to rapidly develop photodynamic theragnostic agents10.1002/chem.201904257 ↗
3. Activatable photosensitizers: agents for selective photodynamic therapy
4. Photosensitized singlet oxygen and its applications10.1016/S0010-8545(02)00034-6 ↗
5. Lakowicz · 2006
6. Photophysical properties of the pyrromethene 597 dye: solvent effect10.1021/jp0373898 ↗
7. Conjugated photosensitizers for imaging and PDT in cancer research10.1021/acs.jmedchem.0c00047 ↗
8. Features of third generation photosensitizers used in anticancer photodynamic therapy: Review10.1016/j.pdpdt.2020.102091 ↗
9. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application10.1039/D0CS00173B ↗
10. An artificial light-harvesting array constructed from multiple bodipy dyes10.1021/ja4049306 ↗
11. Blue-to-orange color-tunable laser emission from tailored boron-dipyrromethene dyes10.1002/cphc.201300818 ↗
12. A modular synthesis of unsymmetrical tetraarylazadipyrromethenes10.1021/jo050696k ↗
13. Synthesis, properties, and functionalization of nonsymmetric 8-MethylthioBODIPYs10.1002/ejoc.201600724 ↗
14. Versatile synthetic methods for the engineering of thiophene-substituted Bodipy dyes10.1016/j.tetlet.2009.09.163 ↗
15. BODIPY dyes in photodynamic therapy10.1039/C2CS35216H ↗
16. Controlling Vilsmeier-Haack processes in meso-methylBODIPYs: a new way to modulate finely photophysical properties in boron dipyrromethenes10.1016/j.dyepig.2017.02.030 ↗
17. Photosensitization and controlled photosensitization with BODIPY dyes10.1016/j.ccr.2017.09.029 ↗
18. Exploring BODIPY derivatives as singlet oxygen photosensitizers for PDT10.1111/php.13232 ↗
19. Photoinduced electron transfer-based halogen-free photosensitizers: covalent meso-aryl (phenyl, naphthyl, anthryl, and pyrenyl) as electron donors to effectively induce the formation of the excited triplet state and singlet oxygen for BODIPY compounds10.1002/asia.201700794 ↗
20. In vitro photodynamic studies of a BODIPY-based photosensitizer10.1002/ejoc.201601054 ↗
21. Halogen-containing BODIPY derivatives for photodynamic therapy10.1016/j.dyepig.2018.08.007 ↗
22. Synthesis of BF2 chelates of tetraarylazadipyrromethenes and evidence for their photodynamic therapeutic behaviour10.1039/B204317C ↗
23. The main strategies for tuning BODIPY fluorophores into photosensitizers10.1142/S1088424619300234 ↗
24. Materials for selective photo-oxygenation vs. photocatalysis: preparation, properties and applications in environmental and health fields10.1039/C5CY01929J ↗
25. Recent advances of the near-infrared fluorescent aza-BODIPY dyes10.2174/1385272820666160229224354 ↗
26. In vitro demonstration of the heavy-atom effect for photodynamic therapy10.1021/ja047649e ↗
27. Yellow NIR dye: π-fused bisbenzoBODIPYs with electron-withdrawing groups10.1039/C3OB41996G ↗
28. Dimeric BODIPYs with different linkages: a systematic investigation on structure-properties relationship10.1016/j.tet.2017.10.042 ↗
29. Structural modification strategies for the rational design of red/NIR region BODIPYs10.1039/C4CS00030G ↗
30. BODIPYs in antitumoral and antimicrobial photodynamic therapy: an integrating review10.1016/j.jphotochemrev.2019.04.001 ↗
31. Organelle-Targeted photosensitizers for precision photodynamic therapy10.1021/acsami.1c02019 ↗
32. A general modular approach for the solubility tagging of BODIPY dyes10.1016/j.dyepig.2019.107545 ↗
33. Water soluble distyryl-boradiazaindacenes as efficient photosensitizers for photodynamic therapy10.1039/b612347c ↗
34. Preparation and in vitro photodynamic activities of folate-conjugated distyryl boron dipyrromethene based photosensitizers10.1021/jm4009168 ↗
35. Tumor-activated water-soluble photosensitizers for near-infrared photodynamic cancer therapy10.1021/acsami.8b04710 ↗
36. Synthesis and in vitro photodynamic activities of pegylated distyryl boron dipyrromethene derivatives10.1021/jm101637g ↗
37. Targeted photodynamic killing of breast cancer cells employing heptamannosylated β-cyclodextrin-mediated nanoparticle formation of an adamantane-functionalized BODIPY photosensitizer10.1021/acsami.6b13612 ↗
38. A lysosome-targeted BODIPY as potential NIR photosensitizer for photodynamic therapy10.1016/j.dyepig.2017.07.048 ↗
39. Synthesis and photophysical properties of tumor-targeted water-soluble BODIPY photosensitizers for photodynamic therapy10.3390/molecules25153340 ↗
40. Highly efficient and photostable photosensitizer based on BODIPY chromophore10.1021/ja0528533 ↗
41. Towards improved halogenated BODIPY photosensitizers: clues on structural designs and heavy atom substitution patterns10.1039/C6CP06448E ↗
42. Methylthio BODIPY as a standard triplet photosensitizer for singlet oxygen production: a photophysical study10.1039/C9CP03454D ↗
43. Synthesis and functionalization of new polyhalogenated BODIPY dyes. Study of their photophysical properties and singlet oxygen generation10.1016/j.tet.2011.11.070 ↗
44. Preparation of unsymmetrical distyryl BODIPY derivatives and effects of the styryl substituents on their in vitro photodynamic properties10.1039/c1cc10727e ↗
45. BODIPY-based photosensitizers with intense visible light harvesting ability and high 1O2 quantum yield in aqueous solution10.1039/C4RA08654F ↗
46. An exceptionally long-lived triplet state of red light-absorbing compact phenothiazine-styrylBodipy electron donor/acceptor dyads: a better alternative to the heavy atom-effect?10.1039/C9CC09058D ↗
47. New 8-Amino-BODIPY derivatives: surpassing laser dyes at blue-edge wavelengths10.1002/chem.201003689 ↗
48. Functionalization of the 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY) core10.1016/j.bmcl.2007.10.103 ↗
49. Synthesis of 8-heteroatom-substituted 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene dyes (BODIPY)10.1016/j.tet.2006.03.036 ↗
50. BODIPY-based probes for the fluorescence imaging of biomolecules in living cells10.1039/C5CS00030K ↗
51. Singlet oxygen generation by photodynamic agents10.1016/S1011-1344(96)07349-6 ↗
52. Photodynamic inactivation of multidrug-resistant Staphylococcus aureus by chlorin e6 and red light (λ = 670 nm)10.1016/j.jphotobiol.2016.07.007 ↗
53. Photodynamic therapy in oncology10.1634/theoncologist.11-9-1034 ↗
54. Optimization in solvent selection for chlorin e6 in photodynamic therapy10.1007/s10895-012-1146-x ↗
55. Self-assembly via intermolecular hydrogen-bonding between o-/m-/p-NH2 and BF2 groups on dipyrromethenes10.1016/j.tetlet.2008.07.045 ↗
56. Phosphorescence and fluorescence of phthalocyanines10.1063/1.1676714 ↗
57. Withania somnifera root extract inhibits fatty acid synthesis in prostate cancer cells10.1016/j.jtcme.2020.02.002 ↗
58. Structural, photophysical and lasing properties of pyrromethene dyes10.1080/01442350500270551 ↗
59. BODIPY dyes and their derivatives: syntheses and spectroscopic properties10.1021/cr078381n ↗
60. Design, synthesis and photophysical studies of dipyrromethene-based materials: insights into their applications in organic photovoltaic devices10.1039/C3CS60411J ↗
61. Shedding light on the mitochondrial matrix through a functional membrane transporter10.1039/C9SC04852A ↗
62. meso-Acetoxymethyl BODIPY dyes for photodynamic therapy: improved photostability of singlet oxygen photosensitizers10.1039/c6pp00166a ↗
63. In vitro and in vivo photocytotoxicity of boron dipyrromethene derivatives for photodynamic therapy10.1021/jm901823u ↗
64. Synthesis of BODIPY dyes through postfunctionalization of the boron dipyrromethene core10.1016/j.ccr.2019.213024 ↗
65. Synthesis and photodynamic activity of a panel of BODIPY dyes10.1016/j.jphotobiol.2012.05.010 ↗
66. Selective photoinactivation of protein function through environment-sensitive switching of singlet oxygen generation by photosensitizer10.1073/pnas.0611717105 ↗
67. PH-activatable singlet oxygen-generating boron-dipyrromethenes (BODIPYs) for photodynamic therapy and bioimaging10.1021/acs.jmedchem.9b01873 ↗
68. A compilation of singlet oxygen yields from biologically relevant molecules10.1111/j.1751-1097.1999.tb08240.x ↗
69. Dąbrowski · 2016 · 325
70. Halogen atom effect on photophysical and photodynamic characteristics of derivatives of 5,10,15,20-tetrakis(3-hydroxyphenyl)porphyrin10.1016/j.jphotobiol.2008.04.006 ↗
71. Toward understanding the high PDT efficacy of chlorin e6-polyvinylpyrrolidone formulations: photophysical and molecular aspects of photosensitizer-polymer interaction in vitro10.1016/j.jphotobiol.2008.06.004 ↗
72. Progress of medical lasers: Fundamentals and applications
73. A bifunctional photosensitizer for enhanced fractional photodynamic therapy: singlet oxygen generation in the presence and absence of light10.1002/anie.201511345 ↗
74. Trifluoromethyl boron dipyrromethene derivatives as potential photosensitizers for photodynamic therapy10.3390/molecules23020458 ↗
75. De novo design of phototheranostic sensitizers based on structure-inherent targeting for enhanced cancer ablation10.1021/jacs.8b09117 ↗
76. Endoplasmic reticulum-localized two-photon-absorbing boron dipyrromethenes as advanced photosensitizers for photodynamic therapy10.1021/acs.jmedchem.7b01907 ↗
77. Highly phototoxic transplatin-modified distyryl-BODIPY photosensitizers for photodynamic therapy
78. Amino modified iodinated BODIPY photosensitizer for highly efficient NIR imaging-guided photodynamic therapy with ultralow dose10.1016/j.dyepig.2021.109611 ↗